Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial

The impact of ribavirin (RBV) dosage on sustained virologic response (SVR) rates remains elusive in hepatitis C virus genotype 2 (HCV-2) rapid responders receiving 16 weeks of peginterferon (Peg-IFN) plus RBV. Treatment-naïve HCV-2 patients with rapid virologic response (RVR) received Peg-IFN alfa-2...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Liu, Chen-Hua, Huang, Chung-Feng, Liu, Chun-Jen, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Jou-Wei, Liang, Cheng-Chao, Yang, Sheng-Shun, Lin, Chih-Lin, Su, Tung-Hung, Yang, Hung-Chih, Chen, Pei-Jer, Chen, Ding-Shinn, Chuang, Wan-Long, Kao, Jia-Horng, Yu, Ming-Lung
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4606559/
https://ncbi.nlm.nih.gov/pubmed/26469083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep15255
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi